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Eukaryotic peptidoglycan recognition proteins
(PGRPs) are related to bacterial amidases. In Dro-
sophila, PGRPs bind peptidoglycan and function as
central sensors and regulators of the innate immune
response. PGRP-LC/PGRP-LE constitute the recep-
tor complex in the immune deficiency (IMD) pathway,
which is an innate immune cascade triggered upon
Gram-negative bacterial infection. Here, we present
the functional analysis of the nonamidase, mem-
brane-associated PGRP-LF. We show that PGRP-
LF acts as a specific negative regulator of the IMD
pathway. Reduction of PGRP-LF levels, in the ab-
sence of infection, is sufficient to trigger IMD path-
way activation. Furthermore, normal development
is impaired in the absence of functional PGRP-LF,
a phenotype mediated by the JNK pathway. Thus,
PGRP-LF prevents constitutive activation of both
the JNK and the IMD pathways. We propose a model
in which PGRP-LF keeps the Drosophila IMD path-
way silent by sequestering circulating peptidoglycan.
INTRODUCTION
Innate immune responses are a common feature of metazoan
organisms, which protect against pathogens and opportunistic
microbial infections. They are controlled by signaling pathways
that have been remarkably conserved during evolution. Genetic
analyses have revealed two major signaling cascades in the
immune response of Drosophila (reviewed in Lemaitre and Hoff-
mann, 2007). The Toll pathway, which is primarily activated after
fungal and Gram-positive bacteria infections, controls the ex-
pression of Drosomycin, an antifungal peptide, and many other
genes via the NF-kB family member DIF (De Gregorio et al.,
2001; Irving et al., 2001; Rutschmann et al., 2000a). The second
cascade, known as the IMD pathway, is predominantly triggered
after Gram-negative infection and regulates, via the NF-kB pro-
tein Relish, the synthesis of many antibacterial peptides amongwhich Diptericin (reviewed in Brennan and Anderson, 2004;
Royet et al., 2005). Although the exact signaling events occurring
downstream of PGRP-LC have not yet been completely eluci-
dated, it appears that the IkB kinase complex, dFADD, Dredd,
and Tak1 are all required for Relish activation (Leulier et al.,
2000, 2002; Silverman et al., 2000, 2003; Stoven et al., 2000;
Rutschmann et al., 2000b;Lu et al., 2001; Vidal et al., 2001;
Naitza et al., 2002; Stoven et al., 2003). In addition to activating
IKK (IkB kinase), the activated dTAK1 also stimulates the JNK
signaling module (Silverman et al., 2003; Park et al., 2004; Kallio
et al., 2005). Thus, the PGRP-LC pathway branches out into two
pathways downstream of IMD. By activating JNK, bacterial elic-
itors not only induce activation of antimicrobial peptide (AMP)
genes, but also of genes encoding various cytokines and the
cytoskeletal remodeling components required for phagocytosis
(Boutros et al., 2002; Stronach and Perrimon, 2002). The situa-
tion is further complicated by the fact that the crosstalk between
the NF-kB and the JNK pathways leads to the downregulation of
their respective activities (Park et al., 2004; Kim et al., 2005).
Recently, a wealth of data was gathered on the mechanisms
which link the detection of bacteria and the activation of signaling
pathways in flies. An efficient Toll pathway activation by Gram-
positive bacterial infection requires the function of at least three
soluble proteins, namely PGRP-SA (Michel et al., 2001), PGRP-
SD (Bischoff et al., 2004), and GNBP-1 (Gram-negative binding
protein-1) (Gobert et al., 2003; Pili-Floury et al., 2004). On the
other hand, sensing of Gram-negative bacteria was shown to de-
pend on two other PGRP family members, PGRP-LC (Choe et al.,
2002; Gottar et al., 2002; Ramet et al., 2002) and PGRP-LE
(Takehana et al., 2004; Kaneko et al., 2006). The PGRP-LC
gene cluster encodes putative receptors of the IMD/Relish path-
way that are predicted to be membrane-bound. By alternative
splicing, three different PGRP domains, LCa, LCx, and LCy,
are fused to a common invariant non-PGRP intracytoplasmic do-
main (Werner et al., 2000). Biochemical experiments have shown
that PGRP-LCa itself does not have affinity to PGN but that it can
form heterodimers with LCx when the latter is bound to PGN
(Chang et al., 2005, 2006; Mellroth et al., 2005). The function of
PGRP-LCy is yet unknown. IMD pathway activation also requires
PGRP-LE molecules. As a full-length protein, PGRP-LE acts as
an intracellular receptor for monomeric PGN, whereas a versionCell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc. 293
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cellularly to enhance PGRP-LC-mediated PGN recognition
(Kaneko et al., 2006).
The ability of Drosophila to discriminate between Gram-posi-
tive and Gram-negative bacteria relies mainly on the specific
recognition of different forms of PGN (Leulier et al., 2003; Guan
et al., 2004; Kaneko et al., 2004; Chang et al., 2005, 2006).
Most PGNs from Gram-positive bacteria are Lys-type PGN
and are recognized by PGRP-SA, PGRP-SD, and GNBP-1
(Michel et al., 2001; Gobert et al., 2003; Bischoff et al., 2004).
In PGN of Gram-negative bacteria and Gram-positive Bacilli,
the lysine residue is replaced by meso-diaminopimelic acid
(m-DAP). This second type of PGN (DAP-PGN) is sensed by
PGRP-LC and PGRP-LE receptors, allowing the activation of
the IMD pathway (Takehana et al., 2002, 2004; Leulier et al.,
2003; Kaneko et al., 2004; Stenbak et al., 2004).
PGRPs forma large group of proteins present inmosteukaryotic
organisms, namely in insects and mammals (Yoshida et al., 1996;
Kang et al., 1998; Werner et al., 2000; Liu et al., 2001). They have in
commona 160aminoaciddomainwithstrikingsequencesimilarity
to N-acetylmuramyl-L-alanine amidases (NAMLAA) (EC3.5.1.28).
In some of the PGRPs, the amidase function is conserved, as
documented for Drosophila PGRP-SC1 (Mellroth et al., 2003)
and PGRP-LB (Kim et al., 2003) and for mouse and human
PGRP-L (Gelius et al., 2003; Wang et al., 2003). In others, such
as inDrosophilaPGRP-SA, -SD, -LE, or -LC, the absence of a crit-
ical cysteine residue within the PGRP domain abolishes the enzy-
matic function. It is assumed, on the basis of genetic experiments,
that PGRPs without amidase activity serve as recognition recep-
tors for microbial PGNs. We and others have shown that by de-
grading PGN, PGRPs with amidase activity control the intensity
of the Drosophila immune response and, therefore, act as detoxi-
fying enzymes (Bischoff et al., 2006; Zaidman-Remy et al., 2006). It
has been proposed that Drosophila PGRP proteins could also act
as scavenger receptors, opsonization proteins for phagocytosis,
or even as bactericidal factors for PGRP-SB1 (Garver et al.,
2006; Mellroth and Steiner, 2006). In this context, it was recently
shown thatone amidase PGRP isessential for defense and survival
of the zebrafish embryo during bacterial infections (Li et al., 2007).
In this manuscript, we describe a new function for a PGRP fam-
ilymember inflies.Wedemonstrate thatPGRP-LF isa membrane-
associated receptor that acts as a negative regulator of the IMD
pathway. By genetically interacting with PGRP-LC, PGRP-LF pre-
vents constitutive activation of both the JNK and the IMD path-
ways in the absence of infection. We further show that in the ab-
sence of functional PGRP-LF, normal development is impaired
and that these phenotypes are mediated by the JNK pathway.
This reveals a new role for a PGRP family member and suggests
that the IMD pathway exert both immune and developmental
functions inDrosophila. It also emphasizes the strong requirement
for a tight balance between activation and repression of the im-
mune response in insects, as was recently proposed in mammals.
RESULTS
PGRP-LC Lacking the Intracellular Domain Acts
as a Dominant Negative of the IMD Pathway
In a structure/function analysis of the PGRP-LC receptor, we
have generated deletion constructs of the PGRP-LCa and the294 Cell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc.PGRP-LCx proteins (data not shown for PGRP-LCx, but the re-
sults are similar to those obtained with PGRP-LCa) and tested
their properties when overexpressed in vivo. Consistent with pre-
vious in vitro reports (Choe et al., 2005), overexpression of a con-
struct encoding a PGRP-LCa protein deleted of its extracellular
recognition domain (PGRP-LCa TM+IC) is sufficient to activate
the IMD pathway when expressed in the adult (Figure 1A) and lar-
val (Figure 1B) fat bodies. It can also rescue the susceptibility of
PGRP-LCE12 protein null mutants (Gottar et al., 2002) to infection
by Gram-negative bacteria such as Erwinia carotovora, a bona
fide Drosophila pathogen (Figure 1C). Other constructs contain-
ing only the extracellular domain (PGRP-LCa EC) or the extracel-
lular domain tethered to the membrane (PGRP-LCa TM+EC) are
neither able to activate diptericin transcription in vivo nor able to
rescue the susceptibility of PGRP-LC mutants to Gram-negative
bacterial infection (Figures 1A–1C and data not shown). Further-
more, flies overexpressing PGRP-LC constructs lacking the in-
tracellular domain in an otherwise wild-type background are se-
verely impaired in their ability to activate diptericin transcription
and are highly sensitive to infection by various Gram-negative
bacteria such as E. carotovora, Escherichia coli, and Entero-
bacter cloacae (Figures 1A–1C). These results indicate that
both PGRP-LCa EC and PGRP-LCa TM+EC constructs act as
a dominant negative for IMD pathway activation when overex-
pressed in vivo. No such effects were observed on Toll pathway
activation, as evidenced by drosomycin induction and by resis-
tance to Gram-positive bacterial infection (data not shown).
PGRP-LF Is a Negative Regulator of the IMD Pathway
The structure of the engineered PGRP-LCa TM+EC protein,
which we show to act as a dominant-negative protein for IMD
pathway activation, resembles another PGRP family member,
PGRP-LF (Figure 2A). PGRP-LF is encoded by a gene located
on the third chromosome in close proximity to the PGRP-LC
gene. It contains a 23 amino acid intracellular tail, a putative
transmembrane domain, and two extracellular PGRP motifs
(PGRP-LFw and -z), which exhibit strong sequence similarity
with the PGRP domains of PGRP-LCa and PGRP-LCx (Fig-
ure 2B). This overall structural similarity between PGRP-LF and
PGRP-LCa TM+EC prompted us to test whether PGRP-LF could
function in vivo as a negative regulator of the IMD pathway.
For that, we generated two independent UAS-IR-PGRP-LF
transgenes targeting either the z or the w PGRP domains of
PGRP-LF (Figure 2A). When driven by ubiquitous Gal4 trans-
genes such as hspGal4, they induced a significant reduction of
PGRP-LF protein levels in vivo (Figure 2C). This reduction of
PGRP-LF level in hspGal4;UAS-IR-PGRP-LF larvae and adults
was associated with a constitutive, infection-independent acti-
vation of the IMD pathway visualized either by using a dipteri-
cin-LacZ reporter transgene (Figure 3A) or by measuring dipter-
icin transcription by qRT-PCR (Figure 3B). The levels of diptericin
transcripts observed in the PGRP-LF hypomorphs that we gen-
erated correspond to approximately 20% of the full response
after septic injury by E. coli (Figure 3B). UAS-IR-PGRP-LF-medi-
ated phenotype can be partially rescued by providing ectopic
PGRP-LF (Figure S1 available online) and were not associated
with an increase of PGRP-LC mRNA levels (Figure S2). No acti-
vation of Toll pathway-dependent drosomycin transcription was
observed in hspGal4-UAS-IR-PGRP-LF flies (Figure 3C). Since it
Cell Host & Microbe
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(A) IMD pathway activation as quantified by Diptericin transcription after ectopic expression of PGRP-LCa deletion constructs in the absence of infection (gray
histograms) or after infection by E. coli (black histograms). YG4, YolkGal4. The histograms represent the mean of four independent experiments. Dipt/RpL32
values are compared to 100%, which represent the level of Diptericin induction 6 hr after E. coli injection in WT flies.
(B) Fat bodies from Dipt-LacZ; hspGal4 third-instar larvae carrying various UAS-PGRP-LCa transgenes.
(C) Survival curves after infection by various Gram-negative bacteria. The results presented are representative of three independent experiments. Flies overex-
pressing PGRP-LCa TM+EC domain are highly susceptible to infection by Gram-negative bacteria.has been reported that PGRP-LB and PGRP-SC1/2 mutant flies
present a specific overactivation of the IMD signaling pathway
after bacterial challenge (Bischoff et al., 2006; Zaidman-Remy
et al., 2006), we looked for a similar phenotype in PGRP-LF
hypomorphic mutants. Neither the intensity of the immune
response nor its duration were affected by reducing PGRP-LF
levels in vivo (Figure 3D). In contrast, ectopic expression of
wild-type PGRP-LF, either ubiquitously (hspGal4 driver) or
specifically in the fat body (YolkGal4 driver), was sufficient
to strongly block IMD pathway activation after infection
(Figure 3F) and to render flies sensitive to infection by a number
of Gram-negative bacteria such as E. cloacae (Figure 3H) or
E. carotovora (data not shown). No effects were noted on Toll
pathway activation by Gram-positive bacteria (Figure 3G).
In addition to its control of diptericin transcription in the fat
body during systemic immune response, the IMD pathway reg-
ulates drosomycin gene expression in some epithelia (trachea,
gut, etc.), which is known as the local immune response. By
specifically reducing PGRP-LF levels in the trachea using the
breathlessGal4 (btlGal4) driver, we could activate drosomycin
expression in this tissue (Figure 3E). Here again, a reductionof PGRP-LF levels in vivo provoked phenotypes similar to those
observed after overexpression of PGRP-LC. Altogether, these
results indicate that reducing PGRP-LF levels in vivo leads to
an infection-independent activation of the IMD pathway.
PGRP-LF Is a DAP-Type PGN Binding Protein
It is usually accepted that the IMD pathway is mainly activated by
DAP-type PGN, whereas Lys-type PGN is a better inducer of the
Toll pathway (Leulier et al., 2003). Activation of IMD, but not
of Toll signaling, in PGRP-LF hypomorphs is suggestive of
a DAP-type recognition specificity for this membrane-associ-
ated protein. Previous work on PGRP recognition in various spe-
cies has shown that the ability of different PGRP molecules to
distinguish between Lys- and DAP-type PGN is mainly based
on the nature of three amino acids in the peptidoglycan-binding
groove (Kumar et al., 2005; Swaminathan et al., 2006). The
nature of the amino acid residues present in these positions
in PGRP-LF is also suggestive of a DAP-type binding protein.
To test if PGRP-LF indeed senses DAP-PGN in vivo, we took ad-
vantage of the fact that its overexpression can block IMD path-
way activation after infection. Overexpression of PGRP-LF alsoCell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc. 295
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(A) The PGRP-LF locus and protein organization. The blue bars correspond to the cDNA domains that are targeted by RNAi in this study. The UAS-IR-PGRP-LF2
construct targets both the PGRP-LFw domain ofPGRP-LF and a glucose-1-phosphate uridylyltransferase (UTP) transcribed on the opposite strand. TheUAS-IR-
PGRP-LF1 construct corresponds to PGRP-LF exon 3 and is specific for the PGRP-LFz domain of PGRP-LF. Similar results (Diptericin induction and wing
notchings) were observed using both constructs.
(B) Phylogenetic tree of Drosophila PGRP domains established by bootstrap analysis using MEGA3 software. Numbers corresponds to the percentage of 500
replications.
(C) Western blot showing the reduction of PGRP-LF levels after induction of UAS-IR-PGRP-LF2 RNA with the hspGal4 driver. Third-instar larvae from indicated
genotypes were heat-shocked for 1 hr at 37C. Six hours later, protein extracts were obtained and analyzed by western blot.
(D–F) PGRP-LF levels are reduced in PGRP-LF200 wing imaginal discs. No differences in PGRP-LF levels in WT and PGRP-LF200 mutant have been observed in
other tested larval tissues (fat body and gut).
(G and H) ptcGal4;UAS-IR-PGRP-LF2 third-instar wing imaginal discs stained with anti-PGRP-LF antibody. Whereas the PGRP-LF staining is uniform in the
UAS-IR-PGRP-LF2 control discs (H), the staining is reduced in a stripe (white arrow) running along the anteroposterior compartment boundary that corresponds
to the ptc expression domain in ptcGal4;UAS-IR-PGRP-LF2 wing discs (G).blocked diptericin transcription after injection of highly purified
PGN from E. coli (Figure 3F) but had no effect on Toll activation
after injection of Lys-type PGN from Staphylococcus aureus
(Figure 3G). Consistently, PGRP-LF overexpressing flies are sen-
sitive to infection by Gram-negative bacteria such as E. cloacae
(Figure 3H), but not by Gram-positive bacteria (data not shown).
This confirms that PGRP-LF is a negative regulator of the IMD
pathway and that it has DAP-type rather than Lys-type PGN-
binding specificity in vivo.
PGRP-LF Is a Membrane Protein that Is Not Exclusively
Expressed in Immunocompetent Tissues
To further characterize the in vivo function of the PGRP-LF pro-
tein, we analyzed its tissue distribution and cellular localization.
Using an affinity-purified antibody raised against an epitope in
the PGRP-LFw domain (Figure 2A), we could show that PGRP-
LF is present at the plasma membrane of fat body cells where
it appears as punctuate dots along the cell interfaces (Figures
4A and 4B). Similar membrane localization was observed when
a GFP-tagged version of the protein was expressed in vivo in
fat body cells (Figure 4C) or in vitro in the hemocyte-like S2 cells296 Cell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc.(Figure 4D). Other tissues in which AMP peptide transcription
has been reported (trachea, Malpighian tubules, and proventric-
ulus) express PGRP-LF at the cell surface where it colocalizes
with the plasma membrane-associated protein spectrin (Figures
4E–4H and data not shown). Surprisingly, PGRP-LF was also
detected in tissues that are not directly implicated in the immune
response such as imaginal discs (Figure 2D) or salivary glands
(Figure 4I).
PGRP-LF Loss-of-Function Mutants Have
Developmental Defects
The presence of PGRP-LF protein in tissues with no obvious im-
mune function prompted us to look for a putative role of the pro-
tein in nonimmune organs. For that purpose, we inactivated
PGRP-LF function in the well described larval imaginal discs,
which are the primordia of Drosophila adult structures. Flies car-
rying Gal4 drivers expressed in specific regions of the wing imag-
inal disc (Figure 5A) were crossed toUAS-IR-PGRP-LF lines, and
the resulting phenotypes were characterized. ptcGal4;UAS-IR-
PGRP-LF flies in which PGRP-LF levels are reduced at the an-
tero-posterior wing disc compartment boundary (Figures 2G
Cell Host & Microbe
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(A) Fat bodies from Dipt-lacz;hspGal4;UAS-IR-PGRP-LF2 and Dipt-lacz;hspGal4;UAS-PGRP-LC third-instar larvae stained for b-galactosidade activity following
a 30 min heat shock at 37C. Larvae were stained 6 hr after the end of the heat shock period.
(B and C) Reduction of PGRP-LF RNA levels by RNA interference triggers infection-independent Dipt, but not Drom transcription.
(D) Kinetic of Dipt transcription after E. coli infection is the same in wild-type and PGRP-LF hypomorphs.
(E) Drom-GFP;btlGal4-UAS-PGRP-LCa and Drom-GFP;btlGal4;UAS-IR-PGRP-LF2 early third-instar larvae. Reducing PGRP-LF levels in trachea induce IMD
pathway-dependent Drosomycin production. These larvae died before reaching the late third-instar.
(F and G) Ectopic expression of PGRP-LF blocks Dipt activation by E. coli and by highly purified DAP-type PGN from E. coli, but not Drom activation by S. aureus
and S. aureus PGN.
(H) Flies in which PGRP-LF is overexpressed are sensitive to infection by Gram-negative bacteria such as E. cloacae.and 2H) show a wing scalloping at the distal tip, in the patched
(ptc) expression domain (Figures 5A and 5C). Similarly, wings
in which the PGRP-LF gene is specifically downregulated in
the posterior compartment (using the enGal4 driver) show de-
fects restricted to this domain (Figures 5A and 5D). Because of
our data on the role of PGRP-LF in the immune response, we
postulated that these abnormalities could be consecutive to an
overactivation of the IMD pathway in the wing primordium. In-
deed, activation of this immune signaling cascade (but not of
the Toll pathway, data not shown) by an overexpression of the
PGRP-LC receptor in the wing imaginal disc gives rise to severe
defects in the adult wings (Figure 5B). As expected, if these
phenotypes are associated with IMD pathway activation, wing
notchings in ptcGal4;UAS-IR-PGRP-LF flies are totally sup-
pressed in a PGRP-LCE12 mutant background, further indicating
that PGRP-LC is epistatic to PGRP-LF in this function (Figure 5F).
Although PGRP-LE has been shown to cooperate with PGRP-LC
in Gram-negative bacteria recognition, PGRP-LE mutants were
unable to suppress PGRP-LF mutant phenotypes. To ensurethat the wing phenotypes in PGRP-LF hypomorphic mutants
were not due to off-target effects, a drawback frequently associ-
ated with RNA interference, we decided to generate a loss-of-
function allele for PGRP-LF. We mobilized a P element located
upstream of the PGRP-LF ORF but were unable to generate an
allele in which the PGRP-LF coding region was deleted. How-
ever, we did obtain a mutant allele, named PGRP-LF200, which
contains a defective P element some 900 bp upstream of the
ATG (Figure S3). This mutation is semilethal (Table 1), and the
very few adult escapers emerging from the pupal case show
wing-notching phenotypes similar to those observed with
UAS-IR-PGRP-LF transgenes (Figure 5H). In these mutants,
however, the notching is observed all around the wing margin
and is not restricted to specific domains as with Gal4-driven
RNAi constructs. This phenotype was slightly enhanced over
a deficiency (Figure 5I) uncovering the PGRP-LF locus, suggest-
ing that the PGRP-LF200 allele is a strong hypomorphs, but not
a null allele, as far as the wing phenotype is concerned. These
phenotypes were well correlated with a reduction of PGRP-LFCell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc. 297
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2F) and were rescued by providing ectopic PGRP-LF protein
(Figure S4).
PGRP-LF Prevents JNK Pathway Activation
The epistatic experiments presented above indicate that in the
absence of PGRP-LF, the IMD pathway is constitutively acti-
vated, leading to developmental defects. Since the IMD pathway
branches into Relish and the JNK branches, we asked which of
these IMD downstream components could mediate the notching
phenotypes. Overactivation of the Relish pathway has, to our
knowledge, never been associated with patterning defects,
making it unlikely that NF-kB pathway simple activation could
account for the PGRP-LF mutant phenotypes. The alternative
would be that theses phenotypes are instead due to an inappro-
priate JNK pathway activation. Consistently, the JNK pathway
was previously shown to play a role in disc patterning (Adachi-
Yamada et al., 1999). This was further confirmed by looking at
the phenotypes associated with an overexpression of a constitu-
tive form of hep (hepCA) in the wing imaginal disc (Figure 5G). We
therefore tested whether reducing PGRP-LF levels could also
have an effect on JNK pathway activation in vivo. Using puck-
ered-lacZ as a read out for JNK pathway activation, we show
that flies with reduced PGRP-LF levels activate the JNK pathway
in the fat body cells (Figure 6A). This was ascertained by measur-
ing the levels of puckered and sulfated (two targets of the JNK
pathway; Silverman et al., 2003) transcripts by qRT-PCR after
reducing PGRP-LF levels in vivo (Figure 6B). Using another
Figure 4. PGRP-LF Is a Membrane-Associated Protein
Larval fat body (A and B) and salivary glands (I) stained with an anti-PGRP-LF
antibody. PGRP-LF is expressed at the cell membrane. At higher magnification
(B), individual dots can be seen in fat body cells. (C) Fat body cells of an hspGal4;
UAS-PGRP-LF-GFP larvae stained with DAPI. (D) S2 cells transfected with
ActinGal4 andUAS-PGRP-LF-GFP plasmids. In both tissues, the GFP staining
is membrane associated (E–H) In larval proventriculus, PGRP-LF colocalizes
with spectrin at the cell membrane.298 Cell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc.Figure 5. PGRP-LF Is Epistatic to the JNK Pathway
(A) Wild-type wing in which the engrailed (en, dark gray) and patched (ptc, light
gray) expression domains are highlighted. apterous (ap) is expressed in the
dorsal compartment of the wing (not shown).
(B) Ectopic expression of PGRP-LCx (or LCa, not shown) induces strong wing
notching.
(C and D) Wing phenotypes associated with inactivation of PGRP-LF by RNA
interference. Notching is observed in domains where ptc (C) or en (D) are
expressed.
(E and F) The phenotype of en-Gal4;UAS-IR-PGRP-LF1 is suppressed in
a PGRP-LCE12 background (F) and exacerbated in a IKKkey background.
Notchings can be seen in the proximal part of the wing (black arrow). These
are never observed in en-Gal4;UAS-IR-PGRP-LF1 wings (E).
(G) Wings developed from discs in which a constitutively active form of hemip-
terous (hepCA) has been expressed in the dorsal compartment.
(H) PGRP-LF200 wings exhibit notching in both posterior and anterior compart-
ments.
(I) This notching is exacerbated when the PGRP-LF200 mutation is in trans over
the Df(3L)AC1 deficiency that completely removes PGRP-LF ORF.
(J and K) Epistatic relationship between PGRP-LF200 and NF-kB/JNK pathway
mutants. PGRP-LF200 wing phenotype is not suppressed in Dredd (J), Relish,
and IKKkey. A rescued phenotype is observed in hep1;PGRP-LF200 (K) and
is also obtained when PGRP-LF200 is associated with IMD or TAK loss-of-
function mutations.
(L) Genes whose mutations suppress PGRP-LF200 phenotypes are surrounded
by gray circles.
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some PGRP-LF200 wing disc cells display ectopic JNK pathway
activation and cell death (Figure 6C). These results indicate that
PGRP-LF is a negative regulator of the IMD pathway and is re-
quired to block the constitutive activation of both the down-
stream NF-kB and JNK pathways in vivo.
PGRP-LF Wing Phenotypes Are Suppressed
by Reducing JNK Pathway Levels
Our results suggest that PGRP-LF mutant wing phenotypes
could be due to improper JNK pathway activation. To test this
hypothesis, we conducted epistatic experiments between
PGRP-LF200 and mutations of the Relish and JNK branches.
Both PGRP-LF200 notching phenotypes and their low adult via-
bility were suppressed by reducing IMD, TAK, or hep levels (Fig-
ures 5K and 5L; Table 1). As opposed to this, mutations in
Dredd, Relish, key, or PGRP-LE were unable to rescue the
Table 1. Epistatic Relationship between PGRP-LF Allele and
Components of the IMD/JNK Pathways
Genotypes
% of PGRP-LF200
Homozygous Adults
PGRP-LF200/TM3 0.5%
IMD; PGRP-LF200/TM3 50%
Tak1; PGRP-LF200/TM3 46%
Hep1; PGRP-LF200/TM3 28%
DreddB118; PGRP-LF200/TM3 1%
IKKg; PGRP-LF200/TM3 1%
RelishE20, PGRP-LF200/TM3 2%notching phenotypes (Figure 5J). The phenotypes were even
stronger upon downregulation of the Relish pathway, as illus-
trated in enGal4;key;UAS-IR-PGRP-LF wings, which exhibit
stronger notching than enGal4; UAS-IR-PGRP-LF wings (com-
pare Figure 5D to 5E). This observation is consistent with the al-
ready reported negative regulation of the JNK pathway by the
Relish signaling cascade (Park et al., 2004). We conclude that
developmental defects associated with reduction of PGRP-LF
are due to ectopic activation of the JNK pathway.
DISCUSSION
In Drosophila immune response, AMP gene transcription is de-
pendent on Toll and IMD pathway activation. However, kinetics
of activation of theses cascades were shown to be very different.
Toll pathway activation (as monitored by drosomycin transcrip-
tion) reaches its peak some 24 to 48 hr after infection and then
slowly decreases, whereas IMD pathway activation seems
more tightly regulated. It starts 1 to 2 hr after infection, peaks
at 6 hr, and is usually back to baseline levels within 24 hr. Consis-
tent with these observations, recent reports indicate that it is
physiologically important that IMD pathway activation is strictly
regulated and that it is turned off rapidly after infection.Drosoph-
ila uses various mechanisms to dampen, or at least to control,
the intensity of IMD pathway activation. One reported mecha-
nism is to limit the amount of available elicitor, which can act
as a ligand for the PGRP-LC receptor. Two publications indicate
that this function is mediated in flies by PGRPs with enzymatic
activities (Zaidman-Remy et al., 2006) (Bischoff et al., 2006).
By cleaving DAP-PGN, an active IMD pathway elicitor, PGRPs
with amidases activity such as PGRP-SC1/2 or PGRP-LBFigure 6. Reducing PGRP-LF Activates the JNK Pathway
(A) Dorsal view of hspGal4;UAS-IR-PGRP-LF2;puc-lacZ or hspGal4;puc-lacZ adults 1 hour after a 1 hour heat shock. The strong blue staining (arrow) corre-
sponds to endogenous b-galactosidase expression in pericardiac cells. In the bottom picture, the fat body cells were dissociated from the adult cuticle to better
visualize lac-Z nuclear staining.
(B) Quantitative RT-PCR to measure transcription of puckered and sulfated, two targets of the JNK pathway. Reduction of PGRP-LF is sufficient to trigger
puckered and sulfated transcription.
(C) Ectopic activation of the JNK pathway and ectopic cell death is observed in PGRP-LF200 mutant discs. Using msn-lacZ as a reporter construct for JNK path-
way activation, we could show that some cells of PGRP-LF200 wing disc show ectopic activation of the JNK pathway (white arrows). TUNEL staining shows that
some cells of PGRP-LF200 mutant wing undergo apoptosis, whereas wild-type controls do not. Both discs come from a third-instar larvae, but the PGRP-LF200
disc is smaller probably because of cell death.Cell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc. 299
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men. In doing so, they reduce the intensity and the duration of
the immune response. Downregulation of the immune reaction
is also mediated by intracellular mechanisms. Activation of the
IMD pathway leads to signaling through both the Relish and
the JNK pathways. Since both pathways regulate each other,
this also leads to an attenuated immune response (Kim et al.,
2005; Park et al., 2004).
In all cases reported, the absence of dampening processes has
been associated with pathological consequences for the flies.
Flies mutant for the PGRP-SC1/2 amidases show immune-
induced developmental defects or eventually die after infection,
although their immune response is stronger than in wild-type flies
(Bischoff et al., 2006). Interestingly, wing-notching phenotypes
are also observed in these mutant flies, but they only occur after
infection. This is consistent with the fact that, in contrast to what
we observed in PGRP-LF mutants, the IMD cascade is not consti-
tutively activated in PGRP-SC1/2 flies but only overactivated af-
ter an immune challenge. Mutants in which the levels of AP-1 or
STAT are genetically decreased have reduced viability after bac-
terial infection despite more efficient pathogen clearance (Kim
et al., 2007). Similar results have recently been reported for the
Toll pathway whose activation is regulated by a negative feed-
back loop involving WntD. As a result, WntD mutants produce
higher levels of some antimicrobial peptides but are more sensi-
tive to infection by Listeria monocytogenes (Gordon et al., 2005).
In this manuscript, we report an additional level of regulation of
the IMD pathway by a protein of the PGRP family. We show that
PGRP-LF is a plasma membrane-associated protein required
to prevent constitutive activation of the IMD pathway. In the
absence of PGRP-LF, the IMD and JNK cascades are active at
a significant level in the absence of exogenous bacterial infec-
tion. Genetic epistatis experiments show that the JNK pathway
activation due to loss of PGRP-LF function is sufficient to medi-
ate developmental defects. This study raises several questions:
why is PGRP-LC activated when PGRP-LF is absent, and why
does Drosophila need PGRP-LF to silence the IMD cascade in
the absence of infection?
It has been proposed that PGRP-LC is activated upon dimer-
ization after binding to PGN (Choe et al., 2005; Mellroth et al.,
2005). We also know that a very subtle overexpression of
PGRP-LC in the absence of infection can trigger Relish activa-
tion, probably by forcing dimerization of PGRP-LC (data not
shown). PGRP-LF could therefore act via its binding to PGRP-
LC in the absence of infection, thus preventing its constitutive
dimerization. In this model, the PGRP-LF/PGRP-LC interaction
would be displaced upon PGN binding, therefore allowing IMD
pathway activation. Since our attempts to detect PGRP-LC/
PGRP-LF interactions in vitro (by coimmunoprecipitation) in the
presence or in the absence of PGN have been unsuccessful so
far, we are presently unable to validate this model. Another puta-
tive mode of action for PGRP-LF would be to maintain undetect-
able levels of PGN in the organism. In this model, PGRP-LF is not
physically associated with PGRP-LC but is expressed in the
same cells. We propose that low levels of PGN could be present
in larval or adult hemolymph even in the absence of vigorous
infection. Such a situation could occur when flies feed on con-
taminated food. In this case, the gut local immune response is
sufficient to prevent bacteria proliferation. However, if limited300 Cell Host & Microbe 3, 293–303, May 2008 ª2008 Elsevier Inc.amounts of PGN cross the epithelial barrier and end up in the he-
molymph, these muropeptides could be sequestered by PGRP-
LF and, therefore, would no longer be ready to bind PGRP-LC
and to activate the IMD pathway. As opposed to this, when
PGN levels reach a certain threshold (in the case of strong infec-
tion), PGN binding to PGRP-LF could be saturated and the ex-
cess PGN would become an available ligand to bind and activate
PGRP-LC. In agreement with this latter model, the penetrance of
the phenotypes generated by the reduction of PGRP-LF levels
(diptericin production and wing notching) is not total and, impor-
tantly, is increased by feeding the larvae on bacteria (Figure S5).
Moreover, PGRP-LF hypomorphic larvae raised in the presence
of antibiotics show less wing notchings than sibling larvae raised
in normal conditions (Figure S5). The model is further reinforced
by the fact that the PGRP domains of PGRP-LF are closely re-
lated to those of PGRP-LCa and PGRP-LCx and are therefore
likely to have similar binding specificities. The PGN able to acti-
vate PGRP-LC could therefore be titrated out by PGRP-LF. In
this context, it is of interest that PGRP-LF is the only Drosophila
PGRP member which bears two PGRP domains, which should
increase its capacity to bind PGN. Consistently, a recent report
demonstrates that the z and w domains differ in their affinities
to peptidoglycan (Persson et al., 2007). It is also possible to
imagine that by modulating PGRP-LF levels in different tissues,
the amount of PGN required to activate the IMD pathway in spe-
cific tissues could fluctuate. Further experiments are needed to
formally distinguish between the PGRP-LF/PGRP-LC hetero-
dimer model and the PGN titration model.
Why then should Drosophila prevent activation of the immune
response? One reason could be the need to limit continuous
effector gene transcription, which is highly energy consuming.
Another possibility is that, as shown above, the immune re-
sponse is in itself deleterious for the organism. The fact that
the defects due to PGRP-LF mutations are eliminated by the re-
duction of one JNK pathway component strongly suggests that
the second hypothesis holds true, although both hypotheses are
not mutually exclusive. It has been reported that overactivation
of the IMD pathway induces cell death, and we have evidence
that this is also the case in PGRP-LF mutant (Georgel et al.,
2001; data not shown). Interestingly, in mammals, the TNF path-
way, which shares important similarities with the IMD pathway, is
also tightly regulated. The TRAIL (tumor necrosis factor-related
apoptosis-inducing ligand) triggers apoptosis upon engagement
of its agonistic receptors DR4 and DR5. In addition to the agonis-
tic TRAIL receptors, TRAIL can also bind to the antagonistic
receptors DcR1, which has a glycosylphosphatidylinositol mem-
brane anchor and therefore has no intracellular domain. There is
some evidence that DcR1 acts merely as a competitor for TRAIL
binding, preventing DR5 activation (Merino et al., 2006). We pro-
pose that PGRP-LF has, in flies, a function similar to that of DcR1
in mammals.
Finally, in yet another model, PGRP-LC could be activated not
only by bacterial elicitors but also by self molecules present in
the hemolymph. In this case, PGRP-LF function would be to pre-
vent PGRP-LC activation by titrating out these endogenous
ligands. It is, however, yet unclear whether Drosophila is able
to detect self, and how. In this context, recent reports indicate
that the IMD pathway can be activated in the female genital tract
either directly or indirectly by sex peptides (Peng et al., 2005). It
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pathways in flies.
EXPERIMENTAL PROCEDURES
PGRP-LF Antibodies
An affinity purified antibody directed against the following peptides (pkdadelv-
vafigpsssnkk) was raised in Rabbit by Sigma-genosys.
Immunolocalization
Tissues were dissected in PBS and fixed for 20 min in 4% paraformaldehyde on
ice. After several rinses in PBT (PBS + 0.1% Tween20), they were blocked for
1 hr in PBT-3% BSA at 4C and then incubated in antibody at the appropriate
dilution (1/500 for PGRP-LF) in PBT-BSA3% overnight at 4C. Several rinses in
PBT were followed by a 2 hr incubation in secondary antibody at 4C (Alexa
Fluor 546 goat anti-rat IgG and Alexa Fluor 546 goat anti-rabbit IgG diluted
1:500, Molecular Probes), then 5 rinses in PBT. The tissues were finally
mounted in Vectashield (Vector Laboratories) fluorescent mounting medium.
Microbial Strains
We used the following microbial organisms in this study: Escherichia coli
(1106), Micrococcus luteus (CIP A270), Enterobacter cloacae, Erwinia caroto-
vora, and Staphylococcus aureus.
Drosophila melanogaster Strains and Maintenance
Stocks were raised on standard cornmeal-agar medium at 25C. For antibiotic
treatment, 100 ml of a solution containing 5 mg/ml of Ampicilline and 5 mg/ml of
Kanamycine were added to each vial. Since we used mutants generated in
different genetic backgrounds and numerous double mutants, it was not pos-
sible to have an appropriate wild-type background for each genetic combina-
tion. The wild-type control corresponds here to the stock yw drs-GFP dipt-
LacZ X (DD1) (Ferrandon et al., 1998). However, for most experiments, other
wild-type control stocks (w 5001, OrR, and DD1) were used and shown to
behave similarly. IKKkey1, Tak1, IMD, DreddD55, PGRP-LE112, and PGRP-LCE12
alleles are described elsewhere (Bischoff et al., 2006). UAS-hepCA and hep1
and puc-lacZ and msn-lacZ were described, respectively, in (Adachi-Yamada
et al., 1999; Bosch et al., 2005; Glise et al., 1995).
Septic Injuries and Survival Experiments
Cells from overnight bacterial cultures were recovered by centrifugation at
3000 g for 10 min at room temperature. The supernatant was discarded, and
the pellet was resuspended in fresh LB. Cell suspensions were serially diluted
in PBS, and the concentration of cells was determined by OD measurement.
Flies were anaesthetized with CO2 and infected by pricking the dorsal thorax
with a thin tungsten needle previously dipped into culture of the appropriate
bacterial strains. Survival experiments were carried out at 25C with 25 flies
for each tested genotype. Surviving flies were transferred daily into fresh vials
and counted. Results are expressed as percentage of living flies at different
time points after infection. Each experiment shown in the figures is represen-
tative of at least three independent experiments.
Cloning of PGRP-LC Constructs
PGRP-LC constructs were obtained by PCR with Platinum high fidelity poly-
merase using the following primers: PGRP-LC IC, forward 50-GGAATTC
CAAAATGACGTTGAACCAAAGTAAGATC-30 and 50-GCTCTAGAGCTCAGCG
TCCGACAGTGTTGGGCAG-30; reverse PGRP-LCTM+IC, forward 50-GGAATT
CCAAAATGACGTTGAACCAAAGTAAGATC-30 and reverse 50-GGGTACCCT
CATGCGGCCGCGTTCAACGTCTTTCCGAA-30; forward PGRP-LC EC, 50-GG
AATTCCAAAATGACGTTGAACCAAAGTAAGATC-30 and reverse 50GGGTAC
CCTCACGACCAATGAGTCCAGTT-30; forward PGRP-LC TM+EC, GGAATTC
CAAAATGCGCAAGGCCGTCACAGTTACA-30 and 50-GGGTACCCTCACGAC
CAATGAGTCCAGTT-30. These fragments were then subcloned into pUAST.
After sequencing, the constructs were injected into w1118 embryos.
Generation of UAS-IR-PGRP-LF1, -2, and UAS-PGRP-LF-GFP
The UAS-IR-PGRP-LF1 and -2 plasmids were constructed by inserting PCR
fragments flanked by BamHI and NheI sites between the NheI-BamHI sites(sense) and the XbaI-BglII sites (antisense), respectively, into the RNAi vector
(Naitza et al., 2002). Primers were as follows: UASi-PGRP-LF1, forward 50- G
GGGGATCCTGCGACTCCTAAGCAATGAGA-30 and reverse 50- GGGGCTAG
CCTATGACTTTTCTAAATCGTC-30; UASi-PGRP-LF2, forward 50-GGGGGAT
CCGATGTTTGCATATACCGCATGA-30 and reverse 50-GGGGCTAGCATGAT
GTTGGATCCTGCGTGAAT-30. After sequencing, the constructs were injected
into w1118 embryos. The UAS-PGRP-LF-GFP clone has been obtained using
the Gateway technic and the following primers: forward 50-GGGGACAAGTT
TGTACAAAAAAGCAGGCTCCACCATGCCGAAAACAGTGGTAGTTACTCAC-
30 and reverse 50-GGGGACCACTTTGTACAAGAAAGCTGGGTCTATGACTTT
TCTAAATCGTCAA-30. The construct was either transfected in S2 cells
together with act-Gal4 or injected into w1118 embryos to get UAS-PGRP-LF-
GFP transgenic flies.
Obtention of the PGRP-LF200 Mutant
The PGRP-LF200 mutant was obtained by crossing the p(w+) P element DJ646
(located approximatively 700 pb upstream of the PGRP-LF start codon) with
a source of transposase. The progeny was screened for w flies, which carry
alteration in the promotor region of PGRP-LF. Out of 200 independent lines,
one shows a deletion when compared to the original DJ646 line (Figure S3).
Quantitative Real-Time PCR
This was performed as previously described (Bischoff et al., 2006). The primers
used are 50-GGCCTACAAGCTGGTGAAAG-30 and 50-AGTTCAGATTGGGCG
AGATG-30 for puckered; 50-CGGGAGTGGGGAGGATTG-30 and 50-CTTTGAG
GAGCGGAGGAAGG-30 for sulfated; and 50-AAACGATCCGTTGACTGGAC-30
and 50 TACGCTTGGATTCCGTTTTC-30 for PGRP-LC.
SUPPLEMENTAL DATA
The Supplemental Data include five supplemental figures and can be found
with this article online at http://www.cellhostandmicrobe.com/cgi/content/
full/3/5/293/DC1/.
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